News

Odyssey Health Expands Horizons in Breast Medical Technology

Odyssey Health Expands Horizons in Breast Medical Technology

Odyssey Health's Innovative Entry into Breast Cancer Diagnostics

Odyssey Health, Inc. (OTCQB: ODYY), a cutting-edge medical device company, has made a significant leap by signing a sub-licensing agreement for exclusive worldwide rights to the BreastCheck, a revolutionary non-invasive test designed to detect breast abnormalities. This agreement is a strategic move, managed through its subsidiary Odyssey Medical Devices, Inc., and is currently subject to certain closing conditions.

Introducing BreastCheck: A New Era in Screening

The BreastCheck test is designed for ease of use, allowing individuals to conduct screenings at home in just 15 minutes. With immediate results, the device has proven to be a reliable first line of identification for potential breast issues. Although it does not replace mammograms, BreastCheck serves as an effective initial screening tool. The technology driving BreastCheck is registered with the FDA in the United States, and it also complies with regulations set by authorities in the European Union and the United Kingdom.

Significance of Early Detection

“This is a major milestone in our medical device portfolio,” says Michael Redmond, CEO of Odyssey. With breast cancer survival rates steadily improving through early detection, it is significant to note the rapid rise in the number of diagnoses. For instance, this year, statistics suggest that about 317,000 new cases of invasive breast cancer will be diagnosed in women across the U.S. Awareness is crucial, as statistics indicate that 1 in 8 women in the U.S. will face a breast cancer diagnosis during their lifetime.

The breast cancer diagnostics market is experiencing incredible growth, currently valued in the low tens of billions of dollars. Forecasts indicate this market could double or even more over the next 8 to 10 years, fueled by advancements in technology including imaging, artificial intelligence, genomics, and increased accessibility to healthcare, particularly in emerging markets.

Commercialization and Future Revenue

Odyssey Health anticipates the commercialization of BreastCheck to commence soon, marking a significant transition from a development-centric company to one generating revenue in the medtech sector. This transition is crucial as it reflects Odyssey’s commitment to offer impactful healthcare solutions.

About BreastCheck: A Comprehensive Monitoring Solution

BreastCheck, a creation of Davion Healthcare PLC, is built to provide a safe, accurate, and cost-effective method for routinely monitoring breast health. It complements established procedures such as clinical breast examinations and mammograms. The device measures heat differences in the breast, averaging temperatures in three designated areas. By comparing temperatures and submitting results via the BreastCheck Mobile App, users can receive immediate interpretations.

Understanding Breast Cancer

Globally, breast cancer stands as the most prevalent cancer among women. It arises when abnormal cells in the breast grow uncontrollably, leading to tumors that may spread throughout the body. Current estimates from the American Cancer Society predict around 316,950 invasive and 59,080 non-invasive breast cancer cases in 2025 alone in the United States. Breast cancer accounts for nearly 30% of all new cancers among women. The World Health Organization also reported that in 2022, approximately 2.3 million women worldwide were newly diagnosed with breast cancer, with around 670,000 fatalities from the disease. If current trends continue, projections suggest that by 2050, new breast cancer cases could soar to 3.2 million globally each year.

About Odyssey Health, Inc.

Odyssey Health, Inc. (OTCQB: ODYY) focuses on pioneering life-saving medical technologies. The company aims to create, acquire, and accumulate distinct assets and intellectual properties that drive innovative medical solutions. Odyssey places a strong emphasis on acquiring advancements that display significant clinical utility and offer a substantial market opportunity. Odyssey Medical Devices, Inc. serves as a wholly owned subsidiary of Odyssey Health Inc.

Frequently Asked Questions

What is the purpose of BreastCheck?

BreastCheck is designed as a non-invasive test for early detection of breast abnormalities, providing quick results for home use.

How does BreastCheck work?

The device measures temperature differences in the breast, offering an interpretation of potential abnormalities through a mobile app.

Why is early detection important in breast cancer?

Early detection significantly improves survival rates, allowing for timely and effective medical intervention.

What are the future plans for Odyssey Health?

Odyssey Health plans to commercialize BreastCheck and transition from development to revenue generation in the medical technology field.

What is the broader impact of BreastCheck on the market?

BreastCheck is part of the rapidly evolving breast cancer diagnostics market, which is expected to grow significantly through technological advancements and increased awareness.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 45

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Highmark’s 2026 Rebound Has a Few Asterisks Attached

Updated Category News Views 74

The Headline Needs a Pencil, Not a Highlighter A $1.9 billion net-income figure can look downright thunderous until you separate the cash-generating engine from the accounting cargo strapped to it. Highmark Health reported $26.5 billion in revenue and $741 million in operating income for the nine months ended Sept. 30, 2026. Those are materially better numbers than the...

Continue Reading
Allooloo's 100M Calls Test Capital Markets AI Data

Updated Category News Views 160

Forty-one point nine thousand issuers is a lot of financial clutter to keep straight, and Allooloo says its machines are getting called on to do precisely that at industrial scale. The Vancouver-based company reported on November 20 that its capital-markets data products now receive 100 million AI-agent calls a month—roughly 3.4 million daily, or 39 per second. That is...

Continue Reading
Midterm Voters Put Cost Relief Ahead of Washington Wars

Updated Category News Views 78

Gas pumps and medical bills have a way of humiliating every grand political slogan ever printed. Seven Letter Insight's latest post-election survey says confirmed 2026 midterm voters want the 120th Congress to deal with costs first, particularly gas prices, health care, restoring health care tax credits and energy bills. That is not a glamorous mandate. It is, however,...

Continue Reading
iHeart's 65% Plunge Brings a Fraud Probe Into Focus

Updated Category News Views 71

November 10 did not merely bruise iHeartMedia shareholders; it left the stock closing at $0.61 after a decline of more than 65%. That kind of move gets everybody’s attention, including plaintiffs’ lawyers, and Wolf Haldenstein Adler Freeman & Herz LLP has opened an investigation into potential securities fraud claims involving iHeartMedia, its officers, and its...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 159

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Human Frontier Mission Puts AI Research on Display

Updated Category News Views 45

A laboratory notebook is about to become the real product in this AI experiment. Human Frontier Mission, or HFM, says it will launch globally on Nov. 24, opening a research program where domain specialists frame scientific and engineering problems while autonomous AI agents develop and test possible answers. The unusual bit is not merely handing models difficult work. It...

Continue Reading
TEN Holdings Raises $1.0 Million as Dilution Looms

Updated Category News Views 66

A Small Raise With a Loud Message Nothing says “we need room to breathe” quite like selling 1,492,500 new shares for $0.67 apiece. TEN Holdings closed a roughly $1.0 million gross equity offering on November 20, 2026, and investors in NASDAQ:XHLD ought to look at this for what it is: a modest cash infusion that comes with immediate dilution. The company gets capital;...

Continue Reading
Fraud0-FouAnalytics Takes Aim at Legacy Ad Verification

Updated Category News Views 95

Digital ad measurement has spent years grading its own homework, and that little arrangement may finally be getting some daylight. fraud0 and FouAnalytics say their expanded partnership will give advertisers impression-level visibility into where ads actually rendered, whether apparent humans engaged with them, and where wasted Google Ads spend might be recoverable. The...

Continue Reading

Top 5 Most Recently Viewed Articles

Insights into Carvana's Growing Options Market Activity

Updated Category News Views 105

Carvana's Options Market Activity Investors with substantial capital are displaying a bullish sentiment towards Carvana Co (NYSE: CVNA). This developing trend in the options market is noteworthy and shouldn't be overlooked by market participants. Recent analyses have revealed an intriguing series of activities that hint at significant upcoming developments for Carvana....

Continue Reading
Road Warrior Expands Network with Big Acquisitions

Updated Category News Views 30

A Heavy-Duty Play: Road Warrior's Big Moves You might think in the world of heavy-duty parts and service, things move like a freight train—slow and steady. But here comes Road Warrior Parts & Service, full steam ahead with a string of acquisitions that are shaking up the landscape. If you've been snoozing on this sector, it's time to wake up. The Acquisitions That Are...

Continue Reading
Foresight Group Commences Strategic Share Buyback Programme

Updated Category News Views 358

Foresight Group Commences Strategic Share Buyback Programme Foresight Group Holdings Limited (LSE: FSG), a well-respected leader in investment management for real assets, is pleased to announce a new initiative as part of its ongoing commitment to creating shareholder value. This new share buyback programme, announced recently, underscores its proactive approach to...

Continue Reading
Carvana's New Delivery Service Lifts Stock Prices Significantly

Updated Category News Views 164

Overview of Carvana's Recent Stock Movement Carvana Co (NYSE: CVNA) has seen its stock rise as it introduces new service options. Recently, the company extended its same-day vehicle delivery feature to customers in the San Diego area, marking a significant enhancement in its operations. By allowing locals to receive their purchased vehicles on the same day they place an...

Continue Reading
AI-Powered Travel Transformation in Norway Revealed

Updated Category News Views 130

AI-Driven Travel Meets Norway's Authentic Charm Well, folks, once again we're staring down the barrel of technology going full throttle in the travel game. Mindtrip, the savvy AI-powered travel platform, just inked a deal with the Norwegian Travel Cluster. It's their first tango in Europe, and they're not dipping their toes—they're diving headfirst into the icy fjords....

Continue Reading